China
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.27 B
|
Dec. 31, 2023 | USD 3.32 | NA |
|
China |
|
2 |
USD 216.60 M
|
Dec. 31, 2023 | USD 9.39 | NA |
|
China |
|
3 |
USD 189.56 M
|
Dec. 31, 2023 | USD 2.18 | NA |
|
China |
|
4 |
USD 159.69 M
|
Dec. 31, 2023 | USD 1.54 | NA |
|
China |
|
5 |
USD 145.51 M
|
Dec. 31, 2023 | USD 1.98 | NA |
|
China |
|
6 |
USD 125.08 M
|
Dec. 31, 2023 | USD 2.35 | NA |
|
China |
|
7 |
USD 80.85 M
|
Dec. 31, 2023 | USD 7.07 | NA |
|
China |
|
8 |
USD 75.78 M
|
Dec. 31, 2023 | USD 1.85 | NA |
|
China |
|
9 |
USD 58.43 M
|
Dec. 31, 2023 | USD 0.91 | NA |
|
China |
|
10 |
USD 39.83 M
|
Dec. 31, 2023 | USD 1.70 | NA |
|
China |
|
11 |
USD 35.95 M
|
Dec. 31, 2023 | USD 3.06 | NA |
|
China |
|
12 |
USD 11.40 M
|
Dec. 31, 2023 | USD 1.59 | NA |
|
China |
|
13 |
USD 6.20 M
|
Dec. 31, 2023 | USD 1.58 | NA |
|
China |
|
14 |
USD 496.57 K
|
Dec. 31, 2023 | USD 0.74 | NA |
|
China |
|
15 |
USD -1.18 M
|
Dec. 31, 2023 | USD 0.99 | NA |
|
China |
|
16 |
USD -23.31 M
|
Dec. 31, 2023 | USD 0.75 | NA |
|
China |
|
17 |
USD -129.05 M
|
Dec. 31, 2023 | USD 3.69 | NA |
|
China |
The Vaccines company in China with the highest Operating Cash Flow is Chongqing Zhifei Biological Products Co., Ltd. (Shenzhen Stock Exchange: 300122.SZ) at USD 1.27 B.
The Vaccines company in China with the lowest Operating Cash Flow is CanSino Biologics Inc. (HKSE: 6185.HK) at USD -129.05 M.
The top 10 Vaccines companies in China by Operating Cash Flow are Chongqing Zhifei Biological Products Co., Ltd., Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Hualan Biological Engineering Inc., Walvax Biotechnology Co., Ltd., Shenzhen Kangtai Biological Products Co., Ltd., Hualan Biological Bacterin Inc., Chengdu Kanghua Biological Products Co., Ltd., Wuhan Keqian Biology Co.,Ltd, Jinyu Bio-technology Co., Ltd. and Pulike Biological Engineering, Inc..
The bottom 10 Vaccines companies in China by Operating Cash Flow are CanSino Biologics Inc., AIM Vaccine Co., Ltd., Shanghai Hile Bio-Technology Co., Ltd., Shanghai Shen Lian Biomedical Corporation, Chengdu Olymvax Biopharmaceuticals Inc., Jiangsu gdk Biotechnology Co., Ltd., Changchun BCHT Biotechnology Co., Pulike Biological Engineering, Inc., Jinyu Bio-technology Co., Ltd. and Wuhan Keqian Biology Co.,Ltd.